Associations between serum lipids and hepatitis C antiviral treatment efficacy (Q34124888)

31 July 2017

title

Associations between serum lipids and hepatitis C antiviral treatment efficacy (English)

1 reference

31 July 2017

0 references

1 reference

2

Abdus S Wahed

1 reference

31 July 2017

Darmendra Ramcharran

1

1 reference

31 July 2017

Hari S Conjeevaram

3

1 reference

31 July 2017

Rhobert W Evans

4

1 reference

31 July 2017

Tianyi Wang

5

1 reference

31 July 2017

Steven H Belle

6

1 reference

31 July 2017

Leland J Yee

7

1 reference

31 July 2017

Virahep-C Study Group

8

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 September 2010

1 reference

31 July 2017

1 reference

31 July 2017

volume

52

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

854-863

1 reference

Fluvastatin inhibits hepatitis C replication in humans

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938827

Cellular Determinants of Hepatitis C Virus Assembly, Maturation, Degradation, and Secretion

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938827

Serum-Derived Hepatitis C Virus Infection of Primary Human Hepatocytes Is Tetraspanin CD81 Dependent

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938827

Reliance of host cholesterol metabolic pathways for the life cycle of hepatitis C virus

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938827

Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938827

Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938827

Correlation between beta-lipoprotein levels and outcome of hepatitis C treatment

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938827

The prevalence of hepatitis C virus infection in the United States, 1999 through 2002

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938827

Oxidized low-density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938827

Association between Hepatitis C Virus and Very-Low-Density Lipoprotein (VLDL)/LDL Analyzed in Iodixanol Density Gradients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938827

Hepatitis C virus particles and lipoprotein metabolism.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938827

Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938827

A modified poisson regression approach to prospective studies with binary data

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938827

The burden of hepatitis C in the United States

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938827

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938827

Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938827

Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938827

Changes in serum lipoprotein profile during interferon therapy in chronic hepatitis C.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938827

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938827

Low density lipoprotein receptor as a candidate receptor for hepatitis C virus

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938827

Histological grading and staging of chronic hepatitis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938827

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938827

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938827

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938827

Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1.

5 July 2018

1 reference

Peginterferon alfa-2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1.

21 January 2018

1 reference

Changes in serum lipid concentrations in patients with chronic hepatitis C virus positive hepatitis responsive or non-responsive to interferon therapy

21 January 2018

1 reference

Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: amino acid substitutions in the core region and low-density lipoprotein cholest

21 January 2018

1 reference

Predictors of response of US veterans to treatment for the hepatitis C virus

21 January 2018

1 reference

Development and validation of two models for early prediction of response to therapy in genotype 1 chronic hepatitis C.

21 January 2018

1 reference

HCV and lipoproteins: is oxLDL an Achilles' heel of the Trojan horse?

21 January 2018

1 reference

Binding of human lipoproteins (low, very low, high density lipoproteins) to recombinant envelope proteins of hepatitis C virus

21 January 2018

1 reference

Low density lipoprotein receptor transcripts correlates with liver hepatitis C virus RNA in patients with alcohol consumption

21 January 2018

1 reference

The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus.

21 January 2018

1 reference

Cell surface expression of LDL receptor in chronic hepatitis C: correlation with viral load

21 January 2018

1 reference

Interferon alpha decreases expression of human scavenger receptor class BI, a possible HCV receptor in hepatocytes

21 January 2018

1 reference

Effects of bezafibrate in patients with chronic hepatitis C virus infection: combination with interferon and ribavirin

21 January 2018

1 reference

Atorvastatin does not exhibit antiviral activity against HCV at conventional doses: a pilot clinical trial

21 January 2018

1 reference

Race, insulin resistance and hepatic steatosis in chronic hepatitis C.

21 January 2018

1 reference

Patterns of drug compliance with medications to be taken once and twice daily assessed by continuous electronic monitoring in primary care

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20690192

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Long-term reversal of hypocholesterolaemia in patients with chronic hepatitis C is related to sustained viral response and viral genotype

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20690192

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Baseline cholesterol is associated with the response to antiviral therapy in chronic hepatitis C

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20690192

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/HEP.23796

1 reference

31 July 2017

1 reference

31 July 2017

1 reference